Non-Hodgkin Lymphoma: Current Treatment Progress

Listen Now

Topics Covered

• Overview of Non-Hodgkin Lymphoma (NHL)
• Signs & Symptoms, in the Context of COVID, Omicron & Seasonal Flu
• NHL Staging & Subtypes
• Indolent & Aggressive NHL
• Relapsed & Refractory NHL
• Novel Treatment Approaches
• The Role of Clinical Trials: How Research Adds to Your Treatment Options
• Your Comfort Level with Adherence
• Managing Treatment Side Effects & Symptoms
• Communicating with Your Health Care Team about Quality-of-Life Concerns
• Follow-Up Care Appointments
• Guidelines to Prepare for Telehealth/Telemedicine Appointments, including Technology, Prepared List of Questions & Discussion of OpenNotes
• Questions for Our Panel of Experts

Our Panel of Experts

Andrew M. Evens, DO, MSc, FACP

Associate Vice Chancellor, Clinical Innovation & Data Analytics, Rutgers Biomedical and Health Sciences, Associate Director (Clinical Services), Rutgers Cancer Institute of New Jersey, System Director of Medical Oncology, and Oncology Lead for RWJBarnabas-Rutgers Medical Group, RWJBarnabas Health, Professor of Medicine, Rutgers Robert Wood Johnson Medical School

Thomas M. Habermann, MD

Professor of Medicine, Mayo Clinic College of Medicine

Christina Poh, MD

Physician, Seattle Cancer Care Alliance, Clinical Assistant Professor, Division of Medical Oncology, University of Washington School of Medicine

Carolyn Messner, DSW, BCD, FAPOS, FAOSW

Senior Director of Education and Training, CancerCare

Brochure

You can download the brochure for this workshop

Workshop Date

This workshop was originally recorded on March 23, 2023.